1. Home
  2. GLBE vs TLX Comparison

GLBE vs TLX Comparison

Compare GLBE & TLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLBE
  • TLX
  • Stock Information
  • Founded
  • GLBE 2013
  • TLX 2015
  • Country
  • GLBE Israel
  • TLX Australia
  • Employees
  • GLBE N/A
  • TLX N/A
  • Industry
  • GLBE Computer Software: Prepackaged Software
  • TLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GLBE Technology
  • TLX Health Care
  • Exchange
  • GLBE Nasdaq
  • TLX Nasdaq
  • Market Cap
  • GLBE 5.5B
  • TLX 6.0B
  • IPO Year
  • GLBE 2021
  • TLX N/A
  • Fundamental
  • Price
  • GLBE $36.22
  • TLX $18.85
  • Analyst Decision
  • GLBE Strong Buy
  • TLX Strong Buy
  • Analyst Count
  • GLBE 13
  • TLX 1
  • Target Price
  • GLBE $52.38
  • TLX $22.00
  • AVG Volume (30 Days)
  • GLBE 2.4M
  • TLX 33.1K
  • Earning Date
  • GLBE 05-19-2025
  • TLX 01-01-0001
  • Dividend Yield
  • GLBE N/A
  • TLX N/A
  • EPS Growth
  • GLBE N/A
  • TLX 798.14
  • EPS
  • GLBE N/A
  • TLX 0.09
  • Revenue
  • GLBE $752,764,000.00
  • TLX $484,687,790.00
  • Revenue This Year
  • GLBE $27.61
  • TLX N/A
  • Revenue Next Year
  • GLBE $25.13
  • TLX N/A
  • P/E Ratio
  • GLBE N/A
  • TLX $199.81
  • Revenue Growth
  • GLBE 32.08
  • TLX 55.85
  • 52 Week Low
  • GLBE $26.64
  • TLX $13.61
  • 52 Week High
  • GLBE $63.69
  • TLX $30.36
  • Technical
  • Relative Strength Index (RSI)
  • GLBE 52.55
  • TLX N/A
  • Support Level
  • GLBE $31.01
  • TLX N/A
  • Resistance Level
  • GLBE $36.87
  • TLX N/A
  • Average True Range (ATR)
  • GLBE 2.47
  • TLX 0.00
  • MACD
  • GLBE 0.84
  • TLX 0.00
  • Stochastic Oscillator
  • GLBE 91.24
  • TLX 0.00

About GLBE Global-E Online Ltd.

Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from and anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.

About TLX Telix Pharmaceuticals Limited American Depositary Shares

Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.

Share on Social Networks: